256 related articles for article (PubMed ID: 33848386)
1. High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation.
Asai S; Sumiyoshi S; Yamada Y; Tateya I; Nagao T; Minamiguchi S; Haga H
Pathol Int; 2021 Jun; 71(6):427-434. PubMed ID: 33848386
[TBL] [Abstract][Full Text] [Related]
2. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
3. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
Su YJ; Lee YH; Jin YT; Hsieh MS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
[TBL] [Abstract][Full Text] [Related]
4. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
Xu B; Haroon Al Rasheed MR; Antonescu CR; Alex D; Frosina D; Ghossein R; Jungbluth AA; Katabi N
Histopathology; 2020 Feb; 76(3):375-382. PubMed ID: 31448442
[TBL] [Abstract][Full Text] [Related]
5. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
[TBL] [Abstract][Full Text] [Related]
6. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
[TBL] [Abstract][Full Text] [Related]
7. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
8. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M
Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
10. Secretory carcinoma of the sinonasal cavity and pharynx: A retrospective analysis of four cases and literature review.
Yue C; Zhao X; Ma D; Piao Y
Ann Diagn Pathol; 2022 Dec; 61():152052. PubMed ID: 36270241
[TBL] [Abstract][Full Text] [Related]
11. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
[TBL] [Abstract][Full Text] [Related]
12. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
14. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
[TBL] [Abstract][Full Text] [Related]
15. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of mammary analogue secretory carcinoma of salivary glands].
Zhang XP; Ni H; Wang X; Chen H; Shi SS; Yu B; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):34-37. PubMed ID: 28072974
[No Abstract] [Full Text] [Related]
17. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
[TBL] [Abstract][Full Text] [Related]
18. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract][Full Text] [Related]
19. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M
Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065
[TBL] [Abstract][Full Text] [Related]
20. High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::NTRK3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.
Klubíčková N; Mosaieby E; Ptáková N; Trinquet A; Laé M; Costes-Martineau V; Skálová A
Virchows Arch; 2023 Aug; 483(2):187-195. PubMed ID: 37415052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
